Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BESIDE: Mirabegron Add-on to Solifenacin in OAB
NCT01908829Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 31
01
Overview
A Phase 3 trial of mirabegron in overactive bladder (OAB), sponsored by Astellas Pharma. Started Jul 2013; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01908829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908829.